One Touch Advanced Topical Anesthetic Strawberry Ice label

One Touch Advanced Topical Anesthetic Strawberry Ice

One Touch Advanced Topical Anesthetic Strawberry Ice Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Indications
OneTouch Advanced Gel is a topical anesthetic indicated for the production
of anesthesia of all accessible mucous membrane except the eyes. OneTouch
Advanced Gel is indicated for use to control pain in the mouth.

History

There is currently no drug history available for this drug.

Other Information

OneTouch
Advanced

Topical Anesthetic Gel                                                                                                                                                                           Rx Only

Active Ingredients:
Benzocaine 14.0%
Butamben 2.0%
Tetracaine Hydrochloride 2.0%

One Touch Advanced Topical Anesthetic Strawberry Ice Manufacturers

  • Hager Worldwide, Inc.
    One Touch Advanced Topical Anesthetic Strawberry Ice | Hager Worldwide, Inc.
    No Recall

    One Touch Advanced Topical Anesthetic Strawberry Ice | Hager Worldwide, Inc.

    One Touch Advanced Topical Anesthetic Strawberry Ice | Hager Worldwide, Inc.

    Dosage and Administration
    Only a limited quantity is OneTouch Advanced Gel is required for anesthesia.

    Dispense 200 mg of gel (a bead approximately 1/4 to 1/2 inches long) by gently
    depressing the pump.  Dispensing a bead of gel in excess of 400 mg is contrain-­
    dicated. Spread thinly and evenly over the desired area using a cotton swab.

    An appropriate pediatric dosage has not been established for OneTouch Ad-­
    vanced Gel.

    Dosages should be reduced in the debilitated elderly, acutely ill, and very young
    patients.

    Tissue need not be dried prior to application of OneTouch Advanced Gel. One-
    Touch Advanced Gel should be applied directly to the site where pain control is
    required. Anesthesia is produced within one minute with an approximate duration
    of thirty minutes. Each 200 mg dose of OneTouch Advanced Gel contains 28 mg
    of benzocaine, 4 mg of butamben and 4 mg of tetracaine HCI.